{"name": "Presidio Pharmaceuticals",
 "permalink": "presidio",
 "crunchbase_url": "http://www.crunchbase.com/company/presidio",
 "homepage_url": "http://www.presidiopharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@presidiopharma.com",
 "phone_number": "+1 (415) 655-7560",
 "description": "biotech trials",
 "created_at": "Thu Jan 15 23:50:19 UTC 2009",
 "updated_at": "Mon Jun 17 03:29:13 UTC 2013",
 "overview": "\u003Cp\u003EPresidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       67],
      "assets/images/resized/0005/4126/54126v2-max-150x150.jpg"],
     [[211,
       95],
      "assets/images/resized/0005/4126/54126v2-max-250x250.jpg"],
     [[211,
       95],
      "assets/images/resized/0005/4126/54126v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CO-Founder and Board Member",
    "person":
     {"first_name": "Johnno",
      "last_name": "Surdam",
      "permalink": "johnno-surdam",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0026/3295/263295v1-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0026/3295/263295v1-max-250x250.jpg"],
          [[187,
            281],
           "assets/images/resized/0026/3295/263295v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Medical Officer and Sr VP, Clinical Development",
    "person":
     {"first_name": "Nathaniel",
      "last_name": "Brown",
      "permalink": "nathaniel-brown-2",
      "image": null}},
   {"is_past": false,
    "title": "President \u0026 Chief Financial Officer",
    "person":
     {"first_name": "Leo",
      "last_name": "Redmond",
      "permalink": "leo-redmond",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0027/5842/275842v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5842/275842v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5842/275842v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President of Chemistry",
    "person":
     {"first_name": "Leping",
      "last_name": "Li",
      "permalink": "leping-li",
      "image": null}},
   {"is_past": false,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Richard",
      "last_name": "Colonno",
      "permalink": "richard-colonno",
      "image": null}},
   {"is_past": false,
    "title": "BOD",
    "person":
     {"first_name": "Kenneth",
      "last_name": "Galbraith",
      "permalink": "kenneth-galbraith-2",
      "image": null}},
   {"is_past": false,
    "title": "BOD",
    "person":
     {"first_name": "Kelvin",
      "last_name": "Neu",
      "permalink": "kelvin-neu",
      "image": null}},
   {"is_past": false,
    "title": "BOD",
    "person":
     {"first_name": "Robert",
      "last_name": "Williamson",
      "permalink": "robert-williamson-2",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Regulatory Affairs",
    "person":
     {"first_name": "Eric",
      "last_name": "Ruby",
      "permalink": "eric-ruby",
      "image": null}},
   {"is_past": false,
    "title": "BOD",
    "person":
     {"first_name": "Scott",
      "last_name": "Lessing",
      "permalink": "scott-lessing",
      "image": null}},
   {"is_past": false,
    "title": "BOD",
    "person":
     {"first_name": "H.",
      "last_name": "Daniel Perez",
      "permalink": "h-daniel-perez-2",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$61.6M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/presidio-rounds-27m-clinical-studies/2009-07-10?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Presidio rounds up $27M for clinical studies",
    "raised_amount": 27000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.presidiopharma.com/docs/Presidio_26M_Series_B.pdf",
    "source_description": "Presidio Pharmaceuticals Closes $26 Million Series B Financing",
    "raised_amount": 26000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 8,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Panorama Capital",
         "permalink": "panorama-capital",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0002/9522/29522v1-max-150x150.png"],
             [[250,
               73],
              "assets/images/resized/0002/9522/29522v1-max-250x250.png"],
             [[305,
               90],
              "assets/images/resized/0002/9522/29522v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Baker Brothers Investments",
         "permalink": "baker-brothers-investments",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bay City Capital",
         "permalink": "bay-city-capital",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0004/8963/48963v1-max-150x150.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-250x250.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventures West",
         "permalink": "ventures-west",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0001/0785/10785v1-max-150x150.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-250x250.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Nexus Medical Partners",
         "permalink": "nexus-medical-partners",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/4129/54129v1-max-150x150.jpg"],
             [[167,
               79],
              "assets/images/resized/0005/4129/54129v1-max-250x250.jpg"],
             [[167,
               79],
              "assets/images/resized/0005/4129/54129v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1467435/000146743513000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 8608981.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 17,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1700 Owens Street, Suite 585",
    "address2": "",
    "zip_code": "94158",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.7679113,
    "longitude": -122.3941495}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        84],
       "assets/images/resized/0005/4127/54127v1-max-150x150.jpg"],
      [[250,
        140],
       "assets/images/resized/0005/4127/54127v1-max-250x250.jpg"],
      [[450,
        252],
       "assets/images/resized/0005/4127/54127v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}